We recentlyshowed that pharmacologically induced lipotoxicityrepresents a promising novel therapeutic strategy for the treatmentof HCC.6 This therapy is based on the activationof de novo fatty acid synthesis in tumor cells viasynthetic agonists of the nuclear receptor and transcription factorliver X receptor alpha (LXRα). The gene discussed is NR1H3; the disease is hepatocellular carcinoma.